Navigation Links
Valeant Pharmaceuticals To Present At 34th Annual Goldman Sachs Global Healthcare Conference
Date:5/20/2013

LAVAL, Quebec, May 20, 2013 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today announced members of its senior management team will make a presentation at the 34th Annual Goldman Sachs Healthcare Conference on Tuesday, June 11, 2013 at 9:20 a.m. PT. The conference will be held at the Terranea Resort in Los Angeles, CA.

A live webcast and audio archive of the presentation will be available on the company's Web site at www.valeant.com. Click on Investor Relations, and then the link to Events and Presentations. Participants should allow approximately five to ten minutes prior to the presentation's start time to visit the site and download any streaming media software needed to listen to the Internet webcast.

About Valeant
Valeant Pharmaceuticals International, Inc. (NYSE/TSX:VRX) is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of dermatology, neurology and branded generics. More information about Valeant can be found at www.valeant.com.

(Logo: http://photos.prnewswire.com/prnh/20101025/LA87217LOGO)

Contact Information:
Laurie W. Little
949-461-6002
laurie.little@valeant.com


'/>"/>
SOURCE Valeant Pharmaceuticals International, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Valeant Pharmaceuticals Announces Resignation of Dr. Laurence Paul from Valeants Board of Directors
2. Valeant Pharmaceuticals To Webcast 2013 Annual Meeting Of Shareholders
3. Valeant Pharmaceuticals International, Inc. Announces Additional Information Regarding Continuance Proposal
4. Valeant Pharmaceuticals Provides Efinconazole Update
5. Valeant Pharmaceuticals Reports 2013 First Quarter Financial Results
6. Actavis Acquires Worldwide Rights for Valeants Metronidazole 1.3% Vaginal Gel
7. Valeant Pharmaceuticals International, Inc. Completes Tender Offer for Obagi Medical Products, Inc.
8. American Skin Association Announces New Member Of The Board J. Michael Pearson And New Education Council Member Ryan Weldon Of Valeant Pharmaceuticals International, Inc.
9. Valeant Pharmaceuticals International, Inc. Announces Receipt of Approval From the Antimonopoly Committee of Ukraine for its Previously Announced Acquisition of Obagi Medical Products, Inc.
10. Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance In The United States For Its Previously Announced Acquisition Of Obagi Medical Products, Inc.
11. Valeant Pharmaceuticals To Announce 2013 First Quarter Results On May 2, 2013
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2020)... ... March 27, 2020 , ... Known for bridging the gap between ... launched a new hand sanitizer in response to the COVID-19 outbreak. , As hand ... continue to expand during the next several months even in the absence of the ...
(Date:3/27/2020)... (PRWEB) , ... March 27, 2020 , ... Why a ... to use the podcast format was because she’d be able to explain more about ... there who are curious, and want to learn more about the process of claim ...
(Date:3/27/2020)... , ... March 27, 2020 , ... ... lifestyle, is privileged to present Dr. Timothy Katzen as a leading weight-loss and ... Haute Living partnership. , Haute Beauty offers a prominent collective of leading doctors ...
Breaking Medicine Technology:
(Date:4/5/2020)... ... April 05, 2020 , ... In the ... our healthcare industry. Nufabrx®, a proprietary biomaterial company that seamlessly embeds active ingredients ... Manufacturing Solutions Center, has shifted production for a new line of reusable copper ...
(Date:4/2/2020)... ... April 02, 2020 , ... FDA ... Webinar, Tuesday April 7, 2020, 1:30-3:00 p.m. EDT, https://www.fdanews.com/cdssoftwareregulation ... AI used to guide clinical management of the Coronavirus.* , Is one’s software ...
(Date:4/2/2020)... ... ... The Northern Virginia Community College Educational Foundation (NOVA Foundation) is proud to ... Beach, Florida. Ms. Howe is adding to her existing endowed scholarship fund to ... than ever given the current pandemic. Ms. Howe has also generously donated to the ...
(Date:4/2/2020)... (PRWEB) , ... April 02, 2020 , ... ... fetuses in their mother’s womb are encouraging their parents, grandparents, and guardians, to ... Purdue—reportedly up to $6 billion in funds will be made available by Purdue ...
(Date:4/1/2020)... ... April 02, 2020 , ... Medical Device Change Management, ... https://www.fdanews.com/mdchangemanagement , What change management method should one be using for ... often dependent on the type of change. Is it due to post-market design change, ...
Breaking Medicine News(10 mins):